Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 47
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sprint interval exercise disrupts mitochondrial ultrastructure driving a unique mitochondrial stress response and remodelling in men

  • Botella, J
  • Perri, E
  • Caruana, N.J
  • López-Calcerrada, S
  • Brischigliaro, M
  • Jamnick. N.A
  • Oorschot, V
  • Saner, N.J
  • Díaz-Lara, J
  • Taylor, D.F
  • Garnham, A
  • Fernández-Vizarra, E
  • Ugalde, C
  • Ramm, G
  • Stroud, D.A
  • Lazarou, M
  • Bishop, D.J
Exercise is a key lifestyle intervention for mitochondrial health, yet the molecular mechanisms by which different exercise prescriptions regulate mitochondrial remodeling remain unclear. We conducted an open-label counterbalanced randomized controlled trial (ACTRN12617001105336) and observed that sprint-interval exercise (SIE; n = 14), compared to moderate-intensity continuous exercise (MICE; n = 14), induces a mitochondrial stress signature and unfolded protein response (UPRmt). SIE triggers morphological and structural mitochondrial alterations along with activation of the integrated stress response (ISR) and mitochondrial quality control (MQC) pathways. Following eight weeks of training, moderate-intensity continuous training (MICT) increases mitochondrial content, complex I activity, and displays an enrichment of tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS) proteins, while sprint-interval training (SIT) improves respiratory function and upregulates pathways involved in 1-carbon metabolism and protein quality control. We identify COX7A2L accumulating in III2 + IV1 supercomplexes only after SIT. These findings elucidate how exercise intensity shapes mitochondrial remodeling, informing tailored exercise prescriptions., This study was supported by grants from the Australian Research Council (Discovery Projects DP140104165 and DP200103542 to D.J.B, and DP200100347 to M.L.), the Australian Physiological Society(Ph.D.granttoJ.B),theAustralian National Health and Medical Research Council (NHMRC Fellowship GNT2009732 to D.A.S. and GNT1106471 to M.L.), and the Rebecca CooperFoundationFellowship(RC20241396toM.L.). WethanktheMito Foundation for the provision of instrumentation through the large equipment grant support scheme (to D.A.S.). C.U. is supported by Min isterio de Ciencia, Innovacion y Universidades, Spain (PID2023 147288NB-I00) and by La Caixa Research Health program (HR24 00604). E.F.-V. is supported by Association Française contre les Myo pathies (AFM)-Téléthon grant number 24962; Gobierno de Aragón, grupos consolidados B33_23R. J.B. was supported by a Victoria University International Postgraduate Research Scholarship and a holarship and a Deakin University Dean’s postdoctoral fellowship., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

In vivo reconstitution of a homodimeric cytochrome b559 like structure: The role of the N-terminus a-subunit from Synechocystis sp. PCC 6803

  • Luján, M.A.
  • Martínez, J.I.
  • Alonso, P.J.
  • Torrado, A.
  • Roncel, M.
  • Ortega, J.M.
  • Sancho, J.
  • Picorel, R.
The cytochrome b559 is a heme-bridged heterodimeric protein with two subunits, a and ß. Both subunits from Synechocystis sp. PCC 6803 have previously been cloned and overexpressed in Escherichia coli and in vivo reconstitution experiments have been carried out. The formation of homodimers in the bacterial membrane with endogenous heme was only observed in the case of the ß-subunit (ß/. ß) but not with the full length a-subunit. In the present work, reconstitution of a homodimer (a/. a) cytochrome b559 like structure was possible using a chimeric N-terminus a-subunit truncated before the amino acid isoleucine 17, eliminating completely a short amphipathic a-helix that lays on the surface of the membrane. Overexpression and in vivo reconstitution in the bacteria was clearly demonstrated by the brownish color of the culture pellet and the use of a commercial monoclonal antibody against the fusion protein carrier, the maltoside binding protein, and polyclonal antibodies against a synthetic peptide of the a-subunit from Thermosynechococcus elongatus. Moreover, a simple partial purification after membrane solubilization with Triton X-100 confirmed that the overexpressed protein complex corresponded with the maltoside binding protein-chimeric a-subunit cytochrome b559 like structure. The features of the new structure were determined by UV-Vis, electron paramagnetic resonance and redox potentiometric techniques. Ribbon representations of all possible structures are also shown to better understand the mechanism of the cytochrome b559 maturation in the bacterial cytoplasmic membrane.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

MEvoLib v1.0: The first molecular evolution library for Python

  • Álvarez-Jarreta, J.
  • Ruiz-Pesini, E.
Background: Molecular evolution studies involve many different hard computational problems solved, in most cases, with heuristic algorithms that provide a nearly optimal solution. Hence, diverse software tools exist for the different stages involved in a molecular evolution workflow. Results: We present MEvoLib, the first molecular evolution library for Python, providing a framework to work with different tools and methods involved in the common tasks of molecular evolution workflows. In contrast with already existing bioinformatics libraries, MEvoLib is focused on the stages involved in molecular evolution studies, enclosing the set of tools with a common purpose in a single high-level interface with fast access to their frequent parameterizations. The gene clustering from partial or complete sequences has been improved with a new method that integrates accessible external information (e.g. GenBank''s features data). Moreover, MEvoLib adjusts the fetching process from NCBI databases to optimize the download bandwidth usage. In addition, it has been implemented using parallelization techniques to cope with even large-case scenarios. Conclusions: MEvoLib is the first library for Python designed to facilitate molecular evolution researches both for expert and novel users. Its unique interface for each common task comprises several tools with their most used parameterizations. It has also included a method to take advantage of biological knowledge to improve the gene partition of sequence datasets. Additionally, its implementation incorporates parallelization techniques to enhance computational costs when handling very large input datasets.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Effects of tributyltin chloride on cybrids with or without an ATP synthase pathologic mutation

  • López-Gallardo, E.
  • Llobet, L.
  • Emperador, S.
  • Montoya, J.
  • Ruiz-Pesini, E.
Background: The oxidative phosphorylation system (OXPHOS) includes nuclear chromosome (nDNA)– and mitochondrial DNA (mtDNA)–encoded polypeptides. Many rare OXPHOS disorders, such as striatal necrosis syndromes, are caused by genetic mutations. Despite important advances in sequencing procedures, causative mutations remain undetected in some patients. It is possible that etiologic factors, such as environmental toxins, are the cause of these cases. Indeed, the inhibition of a particular enzyme by a poison could imitate the biochemical effects of pathological mutations in that enzyme. Moreover, environmental factors can modify the penetrance or expressivity of pathological mutations. Objectives: We studied the interaction between mitochondrially encoded ATP synthase 6 (p.MT-ATP6) subunit and an environmental exposure that may contribute phenotypic differences between healthy individuals and patients suffering from striatal necrosis syndromes or other mitochondriopathies. Methods: We analyzed the effects of the ATP synthase inhibitor tributyltin chloride (TBTC), a widely distributed environmental factor that contaminates human food and water, on transmitochondrial cell lines with or without an ATP synthase mutation that causes striatal necrosis syndrome. Doses were selected based on TBTC concentrations previously reported in human whole blood samples. Results: TBTC modified the phenotypic effects caused by a pathological mtDNA mutation. Interestingly, wild-type cells treated with this xenobiotic showed similar bioenergetics when compared with the untreated mutated cells. Conclusions: In addition to the known genetic causes, our findings suggest that environmental exposure to TBTC might contribute to the etiology of striatal necrosis syndromes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Machine learning classifier for identification of damaging missense mutations exclusive to human mitochondrial DNA-encoded polypeptides

  • Martín Navarro, Antonio
  • Gaudioso Simón, Andrés
  • Álvarez Jarreta, Jorge
  • Montoya, Julio
  • Mayordomo, Elvira
  • Ruiz Pesini, Eduardo
Background: Several methods have been developed to predict the pathogenicity of missense mutations but none has been specifically designed for classification of variants in mtDNA-encoded polypeptides. Moreover, there is not available curated dataset of neutral and damaging mtDNA missense variants to test the accuracy of predictors. Because mtDNA sequencing of patients suffering mitochondrial diseases is revealing many missense mutations, it is needed to prioritize candidate substitutions for further confirmation. Predictors can be useful as screening tools but their performance must be improved. Results: We have developed a SVM classifier (Mitoclass.1) specific for mtDNA missense variants. Training and validation of the model was executed with 2,835 mtDNA damaging and neutral amino acid substitutions, previously curated by a set of rigorous pathogenicity criteria with high specificity. Each instance is described by a set of three attributes based on evolutionary conservation in Eukaryota of wildtype and mutant amino acids as well as coevolution and a novel evolutionary analysis of specific substitutions belonging to the same domain of mitochondrial polypeptides. Our classifier has performed better than other web-available tested predictors. We checked performance of three broadly used predictors with the total mutations of our curated dataset. PolyPhen-2 showed the best results for a screening proposal with a good sensitivity. Nevertheless, the number of false positive predictions was too high. Our method has an improved sensitivity and better specificity in relation to PolyPhen-2. We also publish predictions for the complete set of 24,201 possible missense variants in the 13 human mtDNA-encoded polypeptides. Conclusions: Mitoclass.1 allows a better selection of candidate damaging missense variants from mtDNA. A careful search of discriminatory attributes and a training step based on a curated dataset of amino acid substitutions belonging exclusively to human mtDNA genes allows an improved performance. Mitoclass.1 accuracy could be improved in the future when more mtDNA missense substitutions will be available for updating the attributes and retraining the model.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Severe Septic Patients with Mitochondrial DNA Haplogroup JT Show Higher Survival Rates: A Prospective, Multicenter, Observational Study

  • Lorente, L.
  • Iceta, R.
  • Martín, M.M.
  • López-Gallardo, E.
  • Solé-Violán, J.
  • Blanquer, J.
  • Labarta, L.
  • Díaz, C.
  • Borreguero-León, J.M.
  • Jiménez, A.
  • Montoya, J.
  • Ruiz-Pesini, E.
Objective In a previous cohort study (n=96), we found an association between mitochondrial (mt) DNA haplogroup JT and increased survival of severe septic patients, after controlling for age and serum lactic acid levels. The aim of this research was to increase the predictive accuracy and to control for more confounder variables in a larger cohort (n=196) of severe septic patients, to confirm whether mtDNA haplogroup JT influences short and medium-term survival in these patients. Methods We conducted a prospective, multicenter, observational study in six Spanish Intensive Care Units. We determined 30-day and 6-month survival and mtDNA haplogroup in this second cohort of 196 patients and in the global cohort (first and second cohorts combined) with 292 severe septic patients. Multiple logistic regression and Cox regression analyses were used to test for the association of mtDNA haplogroups JT with survival at 30-days and 6-months, controlling for age, sex, serum interleukin-6 levels and SOFA score. Results Logistic and Cox regression analyses showed no differences in 30-day and 6-month survival between patients with mtDNA haplogroup JT and other haplogroups in the first cohort (n=96). In the second cohort (n=196), these analyses showed a trend to higher 30-day and 6-month survival in those with haplogroup JT. In the global cohort (n=292), logistic and Cox regression analyses showed higher 30-day and 6-month survival for haplogroup JT. There were no significant differences between J and T sub-haplogroups in 30-day and 6-month survival. Conclusions The global cohort study (first and second cohorts combined), the largest to date reporting on mtDNA haplogroups in septic patients, confirmed that haplogroup JT patients showed increased 30-day and 6-month survival. This finding may be due to single nucleotide polymorphism defining the whole haplogroup JT and not separately for J or T sub-haplogroups.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies

  • Kalko, S.G.
  • Paco, S.
  • Jou, C.
  • Rodríguez, M.A.
  • Meznaric, M.
  • Rogac, M.
  • Jekovec-Vrhovsek, M.
  • Sciacco, M.
  • Moggio, M.
  • Fagiolari, G.
  • De Paepe, B.
  • De Meirleir, L.
  • Ferrer, I.
  • Roig-Quilis, M.
  • Munell, F.
  • Montoya, J.
  • López-Gallardo, E.
  • Ruiz-Pesini, E.
  • Artuch, R.
  • Montero, R.
  • Torner, F.
  • Nascimento, A.
  • Ortez, C.
  • Colomer, J.
  • Jimenez-Mallebrera, C.
Background Mutations in the gene encoding thymidine kinase 2 (TK2) result in the myopathic form of mitochondrial DNA depletion syndrome which is a mitochondrial encephalomyopathy presenting in children. In order to unveil some of the mechanisms involved in this pathology and to identify potential biomarkers and therapeutic targets we have investigated the gene expression profile of human skeletal muscle deficient for TK2 using cDNA microarrays. Results We have analysed the whole transcriptome of skeletal muscle from patients with TK2 mutations and compared it to normal muscle and to muscle from patients with other mitochondrial myopathies. We have identified a set of over 700 genes which are differentially expressed in TK2 deficient muscle. Bioinformatics analysis reveals important changes in muscle metabolism, in particular, in glucose and glycogen utilisation, and activation of the starvation response which affects aminoacid and lipid metabolism. We have identified those transcriptional regulators which are likely to be responsible for the observed changes in gene expression. Conclusion Our data point towards the tumor suppressor p53 as the regulator at the centre of a network of genes which are responsible for a coordinated response to TK2 mutations which involves inflammation, activation of muscle cell death by apoptosis and induction of growth and differentiation factor 15 (GDF-15) in muscle and serum. We propose that GDF-15 may represent a potential novel biomarker for mitochondrial dysfunction although further studies are required.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Pharmacologic concentrations of linezolid modify oxidative phosphorylation function and adipocyte secretome

  • Llobet, L.
  • Bayona-Bafaluy, M.P.
  • Pacheu-Grau, D.
  • Torres-Pérez, E.
  • Arbones-Mainar, J.M.
  • Navarro, M.Á.
  • Gómez-Díaz, C.
  • Montoya, J.
  • López-Gallardo, E.
  • Ruiz-Pesini, E.
The oxidative phosphorylation system is important for adipocyte differentiation. Therefore, xenobiotics inhibitors of the oxidative phosphorylation system could affect adipocyte differentiation and adipokine secretion. As adipokines impact the overall health status, these xenobiotics may have wide effects on human health. Some of these xenobiotics are widely used therapeutic drugs, such as ribosomal antibiotics. Because of its similarity to the bacterial one, mitochondrial translation system is an off-target for these compounds. To study the influence of the ribosomal antibiotic linezolid on adipokine production, we analyzed its effects on adipocyte secretome. Linezolid, at therapeutic concentrations, modifies the levels of apolipoprotein E and several adipokines and proteins related with the extracellular matrix. This antibiotic also alters the global methylation status of human adipose tissue-derived stem cells and, therefore, its effects are not limited to the exposure period. Besides their consequences on other tissues, xenobiotics acting on the adipocyte oxidative phosphorylation system alter apolipoprotein E and adipokine production, secondarily contributing to their systemic effects.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

MicroRNA-mediated differential expression of TRMU, GTPBP3 and MTO1 in cell models of mitochondrial-DNA diseases

  • Meseguer, S.
  • Boix, O.
  • Navarro-González, C.
  • Villarroya, M.
  • Boutoual, R.
  • Emperador, S.
  • García-Arumí, E.
  • Montoya, J.
  • Armengod, M.-E.
Mitochondrial diseases due to mutations in the mitochondrial (mt) DNA are heterogeneous in clinical manifestations but usually include OXPHOS dysfunction. Mechanisms by which OXPHOS dysfunction contributes to the disease phenotype invoke, apart from cell energy deficit, maladaptive responses to mitochondria-to-nucleus retrograde signaling. Here we used five different cybrid models of mtDNA diseases to demonstrate that the expression of the nuclear-encoded mt-tRNA modification enzymes TRMU, GTPBP3 and MTO1 varies in response to specific pathological mtDNA mutations, thus altering the modification status of mt-tRNAs. Importantly, we demonstrated that the expression of TRMU, GTPBP3 and MTO1 is regulated by different miRNAs, which are induced by retrograde signals like ROS and Ca2+ via different pathways. Our data suggest that the up- or down-regulation of the mt-tRNA modification enzymes is part of a cellular response to cope with a stoichiometric imbalance between mtDNA- and nuclear-encoded OXPHOS subunits. However, this miRNA-mediated response fails to provide full protection from the OXPHOS dysfunction; rather, it appears to aggravate the phenotype since transfection of the mutant cybrids with miRNA antagonists improves the energetic state of the cells, which opens up options for new therapeutic approaches.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The decrease in mitochondrial DNA mutation load parallels visual recovery in a Leber hereditary optic neuropathy patient

  • Emperador, S.
  • Vidal, M.
  • Hernández-Ainsa, C.
  • Ruiz-Ruiz, C.
  • Woods, D.
  • Morales-Becerra, A.
  • Arruga, J.
  • Artuch, R.
  • López-Gallardo, E.
  • Bayona-Bafaluy, M.P.
  • Montoya, J.
  • Ruiz-Pesini, E.
The onset of Leber hereditary optic neuropathy is relatively rare in childhood and, interestingly, the rate of spontaneous visual recovery is very high in this group of patients. Here, we report a child harboring a rare pathological mitochondrial DNA mutation, present in heteroplasmy, associated with the disease. A patient follow-up showed a rapid recovery of the vision accompanied by a decrease of the percentage of mutated mtDNA. A retrospective study on the age of recovery of all childhood-onset Leber hereditary optic neuropathy patients reported in the literature suggested that this process was probably related with pubertal changes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Retrospective natural history of thymidine kinase 2 deficiency

  • Garone, C.
  • Taylor, R.W.
  • Nascimento, A.
  • Poulton, J.
  • Fratter, C.
  • Dominguez-Gonzalez, C.
  • Evans, J.C.
  • Loos, M.
  • Isohanni, P.
  • Suomalainen, A.
  • Ram, D.
  • Hughes, M.I.
  • McFarland, R.
  • Barca, E.
  • Gomez, C.L.
  • Jayawant, S.
  • Thomas, N.D.
  • Manzur, A.Y.
  • Kleinsteuber, K.
  • Martin, M.A.
  • Kerr, T.
  • Gorman, G.S.
  • Sommerville, E.W.
  • Chinnery, P.F.
  • Hofer, M.
  • Karch, C.
  • Ralph, J.
  • Camara, Y.
  • Madruga-Garrido, M.
  • Dominguez-Carral, J.
  • Ortez, C.
  • Emperador, S.
  • Montoya, J.
  • Chakrapani, A.
  • Kriger, J.F.
  • Schoenaker, R.
  • Levin, B.
  • Thompson, J.L.P.
  • Long, Y.L.
  • Rahman, S.
  • Donati, M.A.
  • DiMauro, S.
  • Hirano, M.
Background Thymine kinase 2 (TK2) is a mitochondrial matrix protein encoded in nuclear DNA and phosphorylates the pyrimidine nucleosides: thymidine and deoxycytidine. Autosomal recessive TK2 mutations cause a spectrum of disease from infantile onset to adult onset manifesting primarily as myopathy. Objective To perform a retrospective natural history study of a large cohort of patients with TK2 deficiency. Methods The study was conducted by 42 investigators across 31 academic medical centres. Results We identified 92 patients with genetically confirmed diagnoses of TK2 deficiency: 67 from literature review and 25 unreported cases. Based on clinical and molecular genetics findings, we recognised three phenotypes with divergent survival: (1) infantile-onset myopathy (42.4%) with severe mitochondrial DNA (mtDNA) depletion, frequent neurological involvement and rapid progression to early mortality (median post-onset survival (POS) 1.00, CI 0.58 to 2.33 years); (2) childhood-onset myopathy (40.2%) with mtDNA depletion, moderate-to-severe progression of generalised weakness and median POS at least 13 years; and (3) late-onset myopathy (17.4%) with mild limb weakness at onset and slow progression to respiratory insufficiency with median POS of 23 years. Ophthalmoparesis and facial weakness are frequent in adults. Muscle biopsies show multiple mtDNA deletions often with mtDNA depletion. Conclusions In TK2 deficiency, age at onset, rate of weakness progression and POS are important variables that define three clinical subtypes. Nervous system involvement often complicates the clinical course of the infantile-onset form while extraocular muscle and facial involvement are characteristic of the late-onset form. Our observations provide essential information for planning future clinical trials in this disorder.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Mitochondrial DNA Haplogroup JT is Related to Impaired Glycaemic Control and Renal Function in Type 2 Diabetic Patients

  • Diaz-Morales, N.
  • Lopez-Domenech, S.
  • Iannantuoni, F.
  • Lopez-Gallardo, E.
  • Sola, E.
  • Morillas, C.
  • Rocha, M.
  • Ruiz-Pesini, E.
  • Victor, V.M.
The association between mitochondrial DNA (mtDNA) haplogroup and risk of type 2 diabetes (T2D) is undetermined and controversial. This study aims to evaluate the impact of the main mtDNA haplogroups on glycaemic control and renal function in a Spanish population of 303 T2D patients and 153 healthy controls. Anthropometrical and metabolic parameters were assessed and mtDNA haplogroup was determined in each individual. Distribution of the different haplogroups was similar in diabetic and healthy populations and, as expected, T2D patients showed poorer glycaemic control and renal function than controls. T2D patients belonging to the JT haplogroup (polymorphism m.4216T>C) displayed statistically significant higher levels of fasting glucose and HbA(1c) than those of the other haplogroups, suggesting a poorer glycaemic control. Furthermore, diabetic patients with the JT haplogroup showed a worse kidney function than those with other haplogroups, evident by higher levels of serum creatinine, lower estimated glomerular filtration rate (eGFR), and slightly higher (although not statistically significant) urinary albumin-to-creatinine ratio. Our results suggest that JT haplogroup (in particular, change at position 4216 of the mtDNA) is associated with poorer glycaemic control in T2D, which can trigger the development of diabetic nephropathy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Las enfermedades raras en las patologías neurometabólicas

  • Montoya, J.
  • Arenas, J.
  • Ruiz-Pesini, E.
  • Martin-Casanueva, M.A.
Las miopatías metabólicas son un grupo de trastornos genéticos que disminuyen la capacidad del músculo esquelético para utilizar sustratos energéticos y sintetizar ATP. Estas alteraciones pueden clasificarse en tres tipos fundamentalmente: i) trastornos del metabolismo de los carbohidratos (del glucógeno y de la glucosa), ii) defectos del metabolismo lipídico, y iii) alteraciones de la fosforilación oxidativa –OXPHOS-. Las dos primeras se deben a deficiencias enzimáticas de las rutas metabólicas de degradación y síntesis de glúcidos y lípidos y muestran diversas manifestaciones clínicas, pero una buena parte de ellas cursan con intolerancia al ejercicio. Aunque un buen número de pacientes con estos trastornos musculares presentan síntomas en la infancia, el diagnóstico normalmente se retrasa hasta la segunda y tercera década de la vida. Por tanto, reconocer las características clínicas de estas deficiencias conduce a un diagnóstico precoz y a un mejor tratamiento. Las enfermedades mitocondriales son un grupo de trastornos originados por una deficiencia en la síntesis de ATP a través del sistema de fosforilación oxidativa. Este sistema está formado por proteínas codificadas en los dos genomas de la célula (nuclear y mitocondrial) y, por tanto, pueden presentar un modelo de herencia mendeliano o materno. En esta revisión se describirán las características especiales del sistema genético mitocondrial y las principales mutaciones que causan enfermedades en humanos. Metabolic myopathies are genetic disorders that decrease the capacity of skeletal muscle to use energy substrates and ATP. These disturbances can be classified into three categories: i) disorders of carbohydrate metabolism (glycogen and glucose), ii) defects in lipid metabolism, and iii) dysfunctions of oxidative phosphorylation -OXPHOS-. The first two are caused by enzyme deficiencies involved in the metabolic pathways of degradation and synthesis of carbohydrates and lipids, and although they show distinct clinical manifestations, exercise intolerance is a predominant symptom present in most of them. Although a good number of patients with these muscle disorders display symptoms in childhood, the diagnosis is often delayed until the second and third decades of life. Therefore, recognizing the clinical features of these deficiencies can lead to an earlier diagnosis and better treatment. Mitochondrial diseases are a group of disorders caused by an alteration of the oxidative phosphorylation system, that leads to a deficient synthesis of ATP. This system is composed of proteins codified in the two genetic systems of the cell, the nuclear and mitochondrial genomes, and, therefore, the mode of inheritance could be either Mendelian or maternal. This review will describe the special characteristics of the mitochondrial genetic system and the main mutations in mtDNA that cause human diseases.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Plasma coenzyme Q10 status is impaired in selected genetic conditions

  • Montero, R.
  • Yubero, D.
  • Salgado, M.C.
  • González, M.J.
  • Campistol, J.
  • O''Callaghan, M.D.M.
  • Pineda, M.
  • Delgadillo, V.
  • Maynou, J.
  • Fernandez, G.
  • Montoya, J.
  • Ruiz-Pesini, E.
  • Meavilla, S.
  • Neergheen, V.
  • García-Cazorla, A.
  • Navas, P.
  • Hargreaves, I.
  • Artuch, R.
Identifying diseases displaying chronic low plasma Coenzyme Q10 (CoQ) values may be important to prevent possible cardiovascular dysfunction. The aim of this study was to retrospectively evaluate plasma CoQ concentrations in a large cohort of pediatric and young adult patients. We evaluated plasma CoQ values in 597 individuals (age range 1 month to 43 years, average 11 years), studied during the period 2005-2016. Patients were classified into 6 different groups: control group of healthy participants, phenylketonuric patients (PKU), patients with mucopolysaccharidoses (MPS), patients with other inborn errors of metabolism (IEM), patients with neurogenetic diseases, and individuals with neurological diseases with no genetic diagnosis. Plasma total CoQ was measured by reverse-phase high-performance liquid chromatography with electrochemical detection and ultraviolet detection at 275¿nm. ANOVA with Bonferroni correction showed that plasma CoQ values were significantly lower in the PKU and MPS groups than in controls and neurological patients. The IEM group showed intermediate values that were not significantly different from those of the controls. In PKU patients, the Chi-Square test showed a significant association between having low plasma CoQ values and being classic PKU patients. The percentage of neurogenetic and other neurological patients with low CoQ values was low (below 8%). In conclusión, plasma CoQ monitoring in selected groups of patients with different IEM (especially in PKU and MPS patients, but also in IEM under protein-restricted diets) seems advisable to prevent the possibility of a chronic blood CoQ suboptimal status in such groups of patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Increasing mtDNA levels as therapy for mitochondrial optic neuropathies

  • Ruiz-Pesini, E.
  • Emperador, S.
  • López-Gallardo, E.
  • Hernández-Ainsa, C.
  • Montoya, J.
Leber hereditary optic neuropathy (LHON) is a rare, inherited mitochondrial disease. No treatment has shown a clear-cut benefit on a clinically meaningful end-point. Primary open-angle glaucoma (POAG) is a frequent, acquired optic neuropathy. Lowering intraocular pressure (IOP) reduces disease progression. However, current methods to decelerate this progression are recognized as being inadequate. Therefore, there is a clear need to look for new therapeutic approaches. The growing evidence indicates that POAG can also be a mitochondrial optic neuropathy (MON). Several risk elements are common for both diseases and all of them decrease mitochondrial (mt)DNA content. Based on these susceptibility factors and their molecular mechanism, we suggest herein pharmacological therapies targeted to increase mtDNA levels, oxidative phosphorylation (OXPHOS) capability, and mitochondrial energy production as treatments for MONs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Food derived respiratory complex I inhibitors modify the effect of Leber hereditary optic neuropathy mutations

  • López-Gallardo, E.
  • Emperador, S.
  • Hernández-Ainsa, C.
  • Montoya, J.
  • Bayona-Bafaluy, M.P.
  • Ruiz-Pesini, E.
Mitochondrial DNA mutations in genes encoding respiratory complex I polypeptides can cause Leber hereditary optic neuropathy. Toxics affecting oxidative phosphorylation system can also cause mitochondrial optic neuropathy. Some complex I inhibitors found in edible plants might differentially interact with these pathologic mutations and modify their penetrance. To analyze this interaction, we have compared the effect of rotenone, capsaicin and rolliniastatin-1 on cybrids harboring the most frequent Leber hereditary optic neuropathy mutations and found that m.3460G > A mutation increases rotenone resistance but capsaicin and rolliniastatin-1 susceptibility. Thus, to explain the pathogenicity of mitochondrial diseases due to mitochondrial DNA mutations, their potential interactions with environment factors will have to be considered.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses

  • Van Bergen, N.J.
  • Guo, Y.
  • Rankin, J.
  • Paczia, N.
  • Becker-Kettern, J.
  • Kremer, L.S.
  • Pyle, A.
  • Conrotte, J.F.
  • Ellaway, C.
  • Procopis, P.
  • Prelog, K.
  • Homfray, T.
  • Baptista, J.
  • Baple, E.
  • Wakeling, M.
  • Massey, S.
  • Kay, D.P.
  • Shukla, A.
  • Girisha, K.M.
  • Lewis, L.E.S.
  • Santra, S.
  • Power, R.
  • Daubeney, P.
  • Montoya, J.
  • Ruiz-Pesini, E.
  • Kovacs-Nagy, R.
  • Pritsch, M.
  • Ahting, U.
  • Thorburn, D.R.
  • Prokisch, H.
  • Taylor, R.W.
  • Christodoulou, J.
  • Linster, C.L.
  • Ellard, S.
  • Hakonarson, H.
Physical stress, including high temperatures, may damage the central metabolic nicotinamide nucleotide cofactors [NAD(P)H], generating toxic derivatives [NAD(P)HX]. The highly conserved enzyme NAD(P)HX dehydratase (NAXD) is essential for intracellular repair of NAD(P)HX. Here we present a series of infants and children who suffered episodes of febrile illness-induced neurodegeneration or cardiac failure and early death. Whole-exome or whole-genome sequencing identified recessive NAXD variants in each case. Variants were predicted to be potentially deleterious through in silico analysis. Reverse-transcription PCR confirmed altered splicing in one case. Subject fibroblasts showed highly elevated concentrations of the damaged cofactors S-NADHX, R-NADHX and cyclic NADHX. NADHX accumulation was abrogated by lentiviral transduction of subject cells with wild-type NAXD. Subject fibroblasts and muscle biopsies showed impaired mitochondrial function, higher sensitivity to metabolic stress in media containing galactose and azide, but not glucose, and decreased mitochondrial reactive oxygen species production. Recombinant NAXD protein harbouring two missense variants leading to the amino acid changes p.(Gly63Ser) and p.(Arg608Cys) were thermolabile and showed a decrease in Vmax and increase in KM for the ATP-dependent NADHX dehydratase activity. This is the first study to identify pathogenic variants in NAXD and to link deficient NADHX repair with mitochondrial dysfunction. The results show that NAXD deficiency can be classified as a metabolite repair disorder in which accumulation of damaged metabolites likely triggers devastating effects in tissues such as the brain and the heart, eventually leading to early childhood death.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Molecular characterization of new FBXL4 mutations in patients with mtDNA depletion syndrome

  • Emperador, Sonia
  • Garrido-Pérez, Nuria
  • Amezcua-Gil, Javier
  • Gaudó, Paula
  • Andrés-Sanz, Julio Alberto
  • Yubero, Delia
  • Fernández-Marmiesse, Ana
  • O'Callaghan, Maria M
  • Ortigoza-Escobar, Juan D.
  • Iriondo, Marti
  • Ruiz-Pesini, Eduardo
  • García-Cazorla, Angels
  • Gil-Campos, Mercedes
  • Artuch, Rafael
  • Montoya, Julio
  • Bayona-Bafaluy, María Pilar
Encephalomyopathic mitochondrial DNA (mtDNA) depletion syndrome 13 (MTDPS13) is a rare genetic disorder caused by defects in F-box leucine-rich repeat protein 4 (FBXL4). Although FBXL4 is essential for the bioenergetic homeostasis of the cell, the precise role of the protein remains unknown. In this study, we report two cases of unrelated patients presenting in the neonatal period with hyperlactacidemia and generalized hypotonia. Severe mtDNA depletion was detected in muscle biopsy in both patients. Genetic analysis showed one patient as having in compound heterozygosis a splice site variant c.858+5G>C and a missense variant c.1510T>C (p.Cys504Arg) in FBXL4. The second patient harbored a frameshift novel variant c.851delC (p.Pro284LeufsTer7) in homozygosis. To validate the pathogenicity of these variants, molecular and biochemical analyses were performed using skin-derived fibroblasts. We observed that the mtDNA depletion was less severe in fibroblasts than in muscle. Interestingly, the cells harboring a nonsense variant in homozygosis showed normal mtDNA copy number. Both patient fibroblasts, however, demonstrated reduced mitochondrial transcript quantity leading to diminished steady state levels of respiratory complex subunits, decreased respiratory complex IV (CIV) activity, and finally, low mitochondrial ATP levels. Both patients also revealed citrate synthase deficiency. Genetic complementation assays established that the deficient phenotype was rescued by the canonical version of FBXL4, confirming the pathological nature of the variants. Further analysis of fibroblasts allowed to establish that increased mitochondrial mass, mitochondrial fragmentation, and augmented autophagy are associated with FBXL4 deficiency in cells, but are probably secondary to a primary metabolic defect affecting oxidative phosphorylation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Uridine Prevents Negative Effects of OXPHOS Xenobiotics on Dopaminergic Neuronal Differentiation

  • Iglesias, Eldris
  • Bayona-Bafaluy, M. Pilar
  • Pesini, Alba
  • Garrido-Pérez, Nuria
  • Meade, Patricia
  • Gaudó, Paula
  • Jiménez-Salvador, Irene
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
Neuronal differentiation appears to be dependent on oxidative phosphorylation capacity. Several drugs inhibit oxidative phosphorylation and might be detrimental for neuronal differentiation. Some pregnant women take these medications during their first weeks of gestation when fetal nervous system is being developed. These treatments might have later negative consequences on the offspring’s health. To analyze a potential negative effect of three widely used medications, we studied in vitro dopaminergic neuronal differentiation of cells exposed to pharmacologic concentrations of azidothymidine for acquired immune deficiency syndrome; linezolid for multidrug-resistant tuberculosis; and atovaquone for malaria. We also analyzed the dopaminergic neuronal differentiation in brains of fetuses from pregnant mice exposed to linezolid. The drugs reduced the in vitro oxidative phosphorylation capacity and dopaminergic neuronal differentiation. This differentiation process does not appear to be affected in the prenatally exposed fetus brain. Nevertheless, the global DNA methylation in fetal brain was significantly altered, perhaps linking an early exposure to a negative effect in older life. Uridine was able to prevent the negative effects on in vitro dopaminergic neuronal differentiation and on in vivo global DNA methylation. Uridine could be used as a protective agent against oxidative phosphorylation-inhibiting pharmaceuticals provided during pregnancy when dopaminergic neuronal differentiation is taking place.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Oxidative phosphorylation inducers fight pathological angiogenesis

  • Bayona-Bafaluy, M.P.
  • Esteban, O.
  • Ascaso, J.
  • Montoya, J.
  • Ruiz-Pesini, E.
Pathological mutations in subunits of the oxidative phosphorylation (OXPHOS) system, or inhibitors of this biochemical pathway, increase the production of vascular endothelial growth factor (VEGF) and pathological angiogenesis. In many angiogenesis-related diseases, such as retinal, rheumatoid diseases, or cancer, OXPHOS dysfunction can be found. Thus, enhancing OXPHOS might be a promising therapeutic approach for pathologic angiogenesis.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Defining the Substrate Spectrum of the TIM22 Complex Identifies Pyruvate Carrier Subunits as Unconventional Cargos

  • Gomkale, R.
  • Cruz-Zaragoza, L.D.
  • Suppanz, I.
  • Guiard, B.
  • Montoya, J.
  • Callegari, S.
  • Pacheu-Grau, D.
  • Warscheid, B.
  • Rehling, P.
In mitochondria, the carrier translocase (TIM22 complex) facilitates membrane insertion of multi-spanning proteins with internal targeting signals into the inner membrane [1–3]. Tom70, a subunit of TOM complex, represents the major receptor for these precursors [2, 4–6]. After transport across the outer membrane, the hydrophobic carriers engage with the small TIM protein complex composed of Tim9 and Tim10 for transport across the intermembrane space (IMS) toward the TIM22 complex [7–12]. Tim22 represents the pore-forming core unit of the complex [13, 14]. Only a small subset of TIM22 cargo molecules, containing four or six transmembrane spans, have been experimentally defined. Here, we used a tim22 temperature-conditional mutant to define the TIM22 substrate spectrum. Along with carrier-like cargo proteins, we identified subunits of the mitochondrial pyruvate carrier (MPC) as unconventional TIM22 cargos. MPC proteins represent substrates with atypical topology for this transport pathway. In agreement with this, a patient affected in TIM22 function displays reduced MPC levels. Our findings broaden the repertoire of carrier pathway substrates and challenge current concepts of TIM22-mediated transport processes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Reseña (Review)

Oxidative phosphorylation dysfunction modifies the cell secretome

  • Garrido-Pérez, Nuria
  • Vela-Sebastián, Ana
  • López-Gallardo, Ester
  • Emperador, Sonia
  • Iglesias, Eldris
  • Meade, Patricia
  • Jiménez-Mallebrera, Cecilia
  • Montoya, Julio
  • Bayona-Bafaluy, M. Pilar
  • Ruiz-Pesini, Eduardo
Mitochondrial oxidative phosphorylation disorders are extremely heterogeneous conditions. Their clinical and genetic variability makes the identification of reliable and specific biomarkers very challenging. Until now, only a few studies have focused on the effect of a defective oxidative phosphorylation functioning on the cell’s secretome, although it could be a promising approach for the identification and pre-selection of potential circulating biomarkers for mitochondrial diseases. Here, we review the insights obtained from secretome studies with regard to oxidative phosphorylation dysfunction, and the biomarkers that appear, so far, to be promising to identify mitochondrial diseases. We propose two new biomarkers to be taken into account in future diagnostic trials.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Ketogenic treatment reduces the percentage of a LHON heteroplasmic mutation and increases mtDNA amount of a LHON homoplasmic mutation.

  • Emperador, Sonia
  • López-Gallardo, Ester
  • Hernández-Ainsa, Carmen
  • Habbane, Mouna
  • Montoya, Julio
  • Bayona-Bafaluy, M. Pilar
  • Ruiz-Pesini, Eduardo
Background: The vision loss in Leber hereditary optic neuropathy patients is due to mitochondrial DNA mutations. No treatment has shown a clear-cut benefit on a clinically meaningful end-point. However, clinical evidences suggest two therapeutic approaches: the reduction of the mutation load in heteroplasmic patients or the elevation of mitochondrial DNA amount in homoplasmic patients. Results: Here we show that ketogenic treatment, in cybrid cell lines, reduces the percentage of the m.13094 T > C heteroplasmic mutation and also increases the mitochondrial DNA levels of the m.11778G > A mitochondrial genotype. Conclusions: These results suggest that ketogenic diet could be a therapeutic strategy for Leber hereditary optic neuropathy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Mitochondrial DNA pathogenic mutations in multiple symmetric lipomatosis

  • López-Gallardo, Ester
  • Cammarata-Scalisi, Francisco
  • Emperador, Sonia
  • Hernández-Ainsa, Carmen
  • Habbane, Mouna
  • Vela-Sebastián, Ana
  • Bayona-Bafaluy, María Pilar
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
The frequency of dermatological manifestations in diseases due to mitochondrial DNA mutations is not well known, although multiple symmetric lipomatosis has been repeatedly associated to mitochondrial DNA mutations. Here, we present a patient suffering from multiple symmetric lipomatosis and other skin signs. We found a new mitochondrial DNA mutation, m.8357T>C, in the tRNALys-coding gene and, using a cybrid approach, confirmed its pathogenicity. A meta-analysis of the dermatological signs of the patient shows that they are not common in patients with confirmed mitochondrial DNA mutations and suggests that, in these cases, lipomatosis is not related to the oxidative phosphorylation dysfunction, but to an alteration of an additional function associated to particular mitochondrial tRNAs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Brain pyrimidine nucleotide synthesis and Alzheimer disease

  • Pesini, Alba
  • Iglesias, Eldris
  • Bayona-Bafaluy, M Pilar
  • Garrido-Pérez, Nuria
  • Meade, Patricia
  • Gaudó, Paula
  • Jiménez-Salvador, Irene
  • Andrés-Benito, Pol
  • Montoya, Julio
  • Ferrer, Isidro
  • Pesini, Pedro
  • Ruiz-Pesini, Eduardo
Many patients suffering late-onset Alzheimer disease show a deficit in respiratory complex IV activity. The de novo pyrimidine biosynthesis pathway connects with the mitochondrial respiratory chain upstream from respiratory complex IV. We hypothesized that these patients would have decreased pyrimidine nucleotide levels. Then, different cell processes for which these compounds are essential, such as neuronal membrane generation and maintenance and synapses production, would be compromised. Using a cell model, we show that inhibiting oxidative phosphorylation function reduces neuronal differentiation. Linking these processes to pyrimidine nucleotides, uridine treatment recovers neuronal differentiation. To unmask the importance of these pathways in Alzheimer disease, we firstly confirm the existence of the de novo pyrimidine biosynthesis pathway in adult human brain. Then, we report altered mRNA levels for genes from both de novo pyrimidine biosynthesis and pyrimidine salvage pathways in brain from patients with Alzheimer disease. Thus, uridine supplementation might be used as a therapy for those Alzheimer disease patients with low respiratory complex IV activity.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Oxidative phosphorylation system and cell culture media

  • Bayona-Bafaluy, M.P.
  • Montoya, J.
  • Ruiz-Pesini, E.
Traditional culture media do not re-semble the metabolic compositionof human blood. The concentrationof different metabolites in thesemedia influences mitochondrialbiogenesis and oxidative phos-phorylation (OXPHOS) function.This knowledge is essential for theinterpretation of results obtainedfrom cellular models used for thestudy of OXPHOS function.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Otros (Other)

Is population frequency a useful criterion to assign pathogenicity to newly described mitochondrial DNA variants?

  • Bayona-Bafaluy, M. Pilar
  • López-Gallardo, Ester
  • Emperador, Sonia
  • Pacheu-Grau, David
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
Population frequency has been one of the most widely used criteria to help assign pathogenicity to newly described mitochondrial DNA variants. However, after sequencing this molecule in thousands of healthy individuals, it has been observed that a very large number of genetic variants have a very low population frequency, which has raised doubts about the utility of this criterion. By analyzing the genetic variation of mitochondrial DNA-encoded genes for oxidative phosphorylation subunits in 195,983 individuals from HelixMTdb that were not sequenced based on any medical phenotype, we show that rare variants are deleterious and, along with other criteria, population frequency is still a useful criterion to assign pathogenicity to newly described variants.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Toxic and nutritional factors trigger Leber hereditary optic neuropathy due to a mitochondrial tRNA mutation

  • Vela-Sebastián, Ana
  • López-Gallardo, Ester
  • Emperador, Sonia
  • Hernández-Ainsa, Carmen
  • Pacheu-Grau, David
  • Blanco, Ignacio
  • Ros, Andrea
  • Pascual-Benito, Ester
  • Rabaneda-Lombarte, Neus
  • Presas-Rodríguez, Silvia
  • García-Robles, Pilar
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
Leber hereditary optic neuropathy is a mitochondrial disease mainly due to pathologic mutations in mitochondrial genes related to the respiratory complex I of the oxidative phosphorylation system. Genetic, physiological, and environmental factors modulate the penetrance of these mutations. We report two patients suffering from this disease and harboring a m.15950G > A mutation in the mitochondrial DNA-encoded gene for the threonine transfer RNA. We also provide evidences supporting the pathogenicity of this mutation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Pathological features in paediatric patients with TK2 deficiency

  • Jou, C.
  • Nascimento, A.
  • Codina, A.
  • Montoya, J.
  • López-Gallardo, E.
  • Emperador, S.
  • Ruiz-Pesini, E.
  • Montero, R.
  • Natera-de Benito, D.
  • Ortez, C. I.
  • Márquez, J.
  • Zelaya, M. V.
  • Gutiérrez-Mata, A.
  • Badosa, C.
  • Carrera-García, L.
  • Expósito-Escudero, J.
  • Roldán, M.
  • Cámara, Y.
  • Marti, R.
  • Ferrer, I.
  • Jiménez-Mallebrera, C.
  • Artuch, R.
Thymidine kinase (TK2) deficiency causes mitochondrial DNA depletion syndrome. We aimed to report the clinical, biochemical, genetic, histopathological, and ultrastructural features of a cohort of paediatric patients with TK2 deficiency. Mitochondrial DNA was isolated from muscle biopsies to assess depletions and deletions. The TK2 genes were sequenced using Sanger sequencing from genomic DNA. All muscle biopsies presented ragged red fibres (RRFs), and the prevalence was greater in younger ages, along with an increase in succinate dehydrogenase (SDH) activity and cytochrome c oxidase (COX)-negative fibres. An endomysial inflammatory infiltrate was observed in younger patients and was accompanied by an overexpression of major histocompatibility complex type I (MHC I). The immunofluorescence study for complex I and IV showed a greater number of fibres than those that were visualized by COX staining. In the ultrastructural analysis, we found three major types of mitochondrial alterations, consisting of concentrically arranged lamellar cristae, electrodense granules, and intramitochondrial vacuoles. The pathological features in the muscle showed substantial differences in the youngest patients when compared with those that had a later onset of the disease. Additional ultrastructural features are described in the muscle biopsy, such as sarcomeric de-structuration in the youngest patients with a more severe phenotype.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Development and characterization of cell models harbouring mtDNA deletions for <i>in vitro</i> study of Pearson syndrome

  • Hernández-Ainsa, Carmen
  • López-Gallardo, Ester
  • García-Jiménez, María Concepción
  • Climent-Alcalá, Francisco José
  • Rodríguez-Vigil, Carmen
  • García Fernández de Villalta, Marta
  • Artuch, Rafael
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
  • Emperador, Sonia
Pearson syndrome is a rare multisystem disease caused by single large-scale mitochondrial DNA deletions (SLSMDs). The syndrome presents early in infancy and is mainly characterised by refractory sideroblastic anaemia. Prognosis is poor and treatment is supportive, thus the development of new models for the study of Pearson syndrome and new therapy strategies is essential. In this work, we report three different cell models carrying an SLMSD: fibroblasts, transmitochondrial cybrids and induced pluripotent stem cells (iPSCs). All studied models exhibited an aberrant mitochondrial ultrastructure and defective oxidative phosphorylation system function, showing a decrease in different parameters, such as mitochondrial ATP, respiratory complex IV activity and quantity or oxygen consumption. Despite this, iPSCs harbouring ‘common deletion’ were able to differentiate into three germ layers. Additionally, cybrid clones only showed mitochondrial dysfunction when heteroplasmy level reached 70%. Some differences observed among models may depend on their metabolic profile; therefore, we consider that these three models are useful for the in vitro study of Pearson syndrome, as well as for testing new specific therapies. This article has an associated First Person interview with the first author of the paper.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Mitochondrial genetic background may impact statins side effects and atherosclerosis development in familial hypercholesterolemia

  • Ruiz Pesini, Eduardo
  • Bayona Bafaluy, María Pilar
  • Sanclemente, Teresa
  • Puzo, José
  • Montoya, Julio
  • Pacheu Grau, David
Heredity of familial hypercholesterolemia (FH) can present as a dominant monogenic disorder of polygenic origin or with no known genetic cause. In addition, the variability of the symptoms among individuals or within the same families evidence the potential contribution of additional factors than monogenic mutations that could modulate the development and severity of the disease. In addition, statins, the lipid-lowering drugs which constitute the first-line therapy for the disease, cause associated muscular symptoms in a certain number of individuals. Here, we analyze the evidence of the mitochondrial genetic variation with a special emphasis on the role of CoQ10 to explain this variability found in both disease symptoms and statins side effects. We propose to use mtDNA variants and copy numbers as markers for the cardiovascular disease development of FH patients and to predict potential statin secondary effects and explore new mechanisms to identify new markers of disease or implement personalized medicine strategies for FH therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Síndrome de Leigh de inicio adulto, con epilepsia mioclónica progresiva, asociado a la mutación m.14487T>C: reporte de caso

  • Segura-Chávez, Darwin
  • Torres-Ramírez, Luis
  • Emperador-Ortiz, Sonia
  • Vélez-Rojas, Miriam
  • Flores-Mendoza, Martha
  • Cosentino-Esquerre, Carlos
  • Ruiz-Pesini, Eduardo
  • Montoya-Villarroya, Julio
El síndrome de Leigh o encefalomielopatía necrotizante subaguda es una enfermedad neurodegenerativa progresiva, genética y clínicamente heterogénea que se asocia por lo general con alteración del metabolismo mitocondrial a nivel de la fosforilación oxidativa. Se presenta generalmente en el periodo neonatal, pero también en la edad adulta, en la que suele expresarse con una combinación de diversas manifestaciones entre ellas parkinsonismo, alteraciones del movimiento, alteraciones neuropsiquiátricas y otras. Caso clínico Paciente masculino de 34 años de edad, que inició sus síntomas a los 18 años, algunos meses después de que su madre falleciera con síntomas parecidos, pero sin diagnóstico definido. El paciente presentó mioclonías progresivas en miembro superior derecho, espasmos palpebrales bilaterales y cervicales, asociándose posteriormente, mioclonia facial desencadenado por el habla y distonía en miembro inferior derecho que le impedía la deambulación. La resonancia magnética de encéfalo mostró la presencia de lesiones simétricas bilaterales en núcleos basales, lesiones corticales y periacueductales. El estudio genético detectó la mutación m.14487T>C en el gen ND6 del complejo 1 del sistema de fosforilación oxidativa mitocondrial en los leucocitos y células de mucosa bucal. El estudio se extendió a la abuela y dos tías maternas, asintomáticas en ese momento, quienes portaban la misma mutación. Conclusión El caso corresponde a un paciente adulto, con síndrome de Leigh, portador de la mutación m.14487T>C, la cual parece estar relacionada con un fenotipo predominantemente mioclónico progresivo, de origen cortical.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease

  • Iglesias, E.
  • Pesini, A.
  • Garrido-Pérez, N.
  • Meade, P.
  • Bayona-Bafaluy, M.P.
  • Montoya, J.
  • Ruiz-Pesini, E.
Late-onset Parkinson disease is a multifactorial and multietiological disorder, age being one of the factors implicated. Genetic and/or environmental factors, such as pesticides, can also be involved. Up to 80% of dopaminergic neurons of the substantia nigra are lost before motor features of the disorder begin to appear. In humans, these neurons are only formed a few weeks after fertilization. Therefore, prenatal exposure to pesticides or industrial chemicals during crucial steps of brain development might also alter their proliferation and differentiation. Oxidative phosphorylation is one of the metabolic pathways sensitive to environmental toxicants and it is crucial for neuronal differentiation. Many inhibitors of this biochemical pathway, frequently found as persistent organic pollutants, affect dopaminergic neurogenesis, promote the degeneration of these neurons and increase the risk of suffering late-onset Parkinson disease. Here, we discuss how an early, prenatal, exposure to these oxidative phosphorylation xenobiotics might trigger a late-onset, old age, Parkinson disease.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Down syndrome is an oxidative phosphorylation disorder

  • Bayona-Bafaluy, M.P.
  • Garrido-Pérez, N.
  • Meade, P.
  • Iglesias, E.
  • Jiménez-Salvador, I.
  • Montoya, J.
  • Martínez-Cué, C.
  • Ruiz-Pesini, E.
Down syndrome is the most common genomic disorder of intellectual disability and is caused by trisomy of chromosome 21. Several genes in this chromosome repress mitochondrial biogenesis. The goal of this study was to evaluate whether early overexpression of these genes may cause a prenatal impairment of oxidative phosphorylation negatively affecting neurogenesis. Reduction in the mitochondrial energy production and a lower mitochondrial function have been reported in diverse tissues or cell types, and also at any age, including early fetuses, suggesting that a defect in oxidative phosphorylation is an early and general event in Down syndrome individuals. Moreover, many of the medical conditions associated with Down syndrome are also frequently found in patients with oxidative phosphorylation disease. Several drugs that enhance mitochondrial biogenesis are nowadays available and some of them have been already tested in mouse models of Down syndrome restoring neurogenesis and cognitive defects. Because neurogenesis relies on a correct mitochondrial function and critical periods of brain development occur mainly in the prenatal and early neonatal stages, therapeutic approaches intended to improve oxidative phosphorylation should be provided in these periods.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Leigh Syndrome in a Pedigree Harboring the m.1555A>G Mutation in the Mitochondrial 12S rRNA

  • Habbane, M.
  • Llobet, L.
  • Bayona-Bafaluy, M.P.
  • Bárcena, J.E.
  • Ceberio, L.
  • Gómez-Díaz, C.
  • Gort, L.
  • Artuch, R.
  • Montoya, J.
  • Ruiz-Pesini, E.
BACKGROUND: Leigh syndrome (LS) is a serious genetic disease that can be caused by mutations in dozens of different genes. METHODS: Clinical study of a deafness pedigree in which some members developed LS. Cellular, biochemical and molecular genetic analyses of patients'' tissues and cybrid cell lines were performed. RESULTS: mitochondrial DNA (mtDNA) m.1555A>G/MT-RNR1 and m.9541T>C/MT-CO3 mutations were found. The first one is a well-known pathologic mutation. However, the second one does not appear to contribute to the high hearing loss penetrance and LS phenotype observed in this family. CONCLUSION: The m.1555A>G pathological mutation, accompanied with an unknown nuclear DNA (nDNA) factor, could be the cause of the phenotypic manifestations in this pedigree.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Developmental origins of Parkinson disease: improving the rodent models

  • Jiménez Salvador, Irene
  • Meade, Patricia
  • Iglesias, Eldris
  • Bayona-Bafaluy, Pilar
  • Ruiz Pesini, Eduardo
Numerous pesticides are inhibitors of the oxidative phosphorylation system. Oxidative phosphorylation dysfunction adversely affects neurogenesis and often accompanies Parkinson disease. Since brain development occurs mainly in the prenatal period, early exposure to pesticides could alter the development of the nervous system and increase the risk of Parkinson disease. Different rodent models have been used to confirm this hypothesis. However, more precise considerations of the selected strain, the xenobiotic, its mode of administration, and the timing of animal analysis, are necessary to resemble the model to the human clinical condition and obtain more reliable results.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Generation of an induced pluripotent stem cell line from a compound heterozygous patient in TK2 gene

  • Hernández-Ainsa, Carmen
  • Nascimento, Andrés
  • Jou, Cristina
  • Artuch, Rafael
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
  • Emperador, Sonia
Autosomal recessive mutations in Thymidine kinase 2 (TK2) gene cause depletion and multiple deletions in mtDNA which normally lead to fatal and progressive neuromyopathy in infants and children. We have generated an induced pluripotent stem cell (iPSC) line by reprogramming fibroblasts derived from a patient carrying TK2 mutations. New iPSC line pluripotency was evaluated by verifying the expression of pluripotency-related genes and the in vitro differentiation into the three germ layers. This human-derived model will be useful for studying the pathogenic mechanisms triggered by these mutations and for testing therapies in cell types normally affected in patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A microscopy-based screen identifies cellular kinases modulating mitochondrial translation

  • Yousefi, Roya
  • Cruz-Zaragoza, Luis Daniel
  • Valpadashi, Anusha
  • Hansohn, Carina
  • Dahal, Drishan
  • Richter-Dennerlein, Ricarda
  • Rizzoli, Silvio
  • Urlaub, Henning
  • Rehling, Peter
  • Pacheu-Grau, David
Mitochondrial DNA encodes 13 subunits of the oxidative phosphorylation (OXPHOS) system, which are synthesized inside the organelle and essential for cellular energy supply. How mitochondrial gene expression is regulated and integrated into cellular physiology is little understood. Here, we perform a high-throughput screen combining fluorescent labeling of mitochondrial translation products with small interfering RNA (siRNA)-mediated knockdown to identify cellular kinases regulating translation. As proof of principle, the screen identifies known kinases that affect mitochondrial translation, and it also reveals several kinases not yet linked to this process. Among the latter, we focus on the primarily cytosolic kinase, fructosamine 3 kinase (FN3K), which localizes partially to the mitochondria to support translation. FN3K interacts with the mitochondrial ribosome and modulates its assembly, thereby affecting translation. Overall, our work provides a reliable approach to identify protein functions for mitochondrial gene expression in a high-throughput manner.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Risk Factors Associated With Leber Hereditary Optic Neuropathy due to Rare Mutations in Mitochondrial <scp>DNA</scp>-Encoded Respiratory Complex I Subunits

  • Bayona-Bafaluy, Pilar
  • Sanz-Pons, Javier
  • Esteban, Olivia
  • Bueno-Borghi, Luca
  • Ruiz-Pesini, Eduardo
An in‐depth analysis of susceptibility factors modifying the penetrance of rare Leber hereditary optic neuropathy‐causing mutations in respiratory complex I genes encoded in mitochondrial deoxyribonucleic acid has not been performed. To bridge this gap, we conducted a review of the literature on rare mutations associated with LHON, selected those with substantial evidence of pathogenicity, and performed an in‐depth analysis of the various pedigrees. Examining the influences that modify the penetrance of the classical mutations associated with this disease may offer insights into susceptibility factors in individuals carrying the rare mutations.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The genetic landscape of mitochondrial diseases in Spain: A nationwide call

  • Bellusci, M.
  • Paredes-Fuentes, A.J.
  • Ruiz-Pesini, E.
  • Gómez, B.
  • Martín, M.A.
  • Montoya, J.
  • Artuch, R.
  • MITOSPAIN Working Group
  • Emperador Ortiz, Sonia
The frequency of mitochondrial diseases (MD) has been scarcely documented, and only a few studies have reported data in certain specific geographical areas. In this study, we arranged a nationwide call in Spain to obtain a global estimate of the number of cases. A total of 3274 cases from 49 Spanish provinces were reported by 39 centres. Excluding duplicated and unsolved cases, 2761 patients harbouring pathogenic mutations in 140 genes were recruited between 1990 and 2020. A total of 508 patients exhibited mutations in nuclear DNA genes (75% paediatric patients) and 1105 in mitochondrial DNA genes (33% paediatric patients). A further 1148 cases harboured mutations in the MT-RNR1 gene (56% paediatric patients). The number of reported cases secondary to nuclear DNA mutations increased in 2014, owing to the implementation of next-generation sequencing technologies. Between 2014 and 2020, excepting MT-RNR1 cases, the incidence was 6.34 (95% CI: 5.71–6.97) cases per million inhabitants at the paediatric age and 1.36 (95% CI: 1.22–1.50) for adults. In conclusion, this is the first study to report nationwide epidemiological data for MD in Spain. The lack of identification of a remarkable number of mitochondrial genes necessitates the systematic application of high-throughput technologies in the routine diagnosis of MD. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Human mitochondrial DNA: Particularities and diseases

  • Habbane, M.
  • Montoya, J.
  • Rhouda, T.
  • Sbaoui, Y.
  • Radallah, D.
  • Emperador, S.
Mitochondria are the cell’s power site, transforming energy into a form that the cell can employ for necessary metabolic reactions. These organelles present their own DNA. Although it codes for a small number of genes, mutations in mtDNA are common. Molecular genetics diagnosis allows the analysis of DNA in several areas such as infectiology, oncology, human genetics and personalized medicine. Knowing that the mitochondrial DNA is subject to several mutations which have a direct impact on the metabolism of the mitochondrion leading to many diseases, it is therefore necessary to detect these mutations in the patients involved. To date numerous mitochondrial mutations have been described in humans, permitting confirmation of clinical diagnosis, in addition to a better management of the patients. Therefore, different techniques are employed to study the presence or absence of mitochondrial mutations. However, new mutations are discovered, and to determine if they are the cause of disease, different functional mitochondrial studies are undertaken using transmitochondrial cybrid cells that are constructed by fusion of platelets of the patient that presents the mutation, with rho osteosarcoma cell line. Moreover, the contribution of next generation sequencing allows sequencing of the entire human genome within a single day and should be considered in the diagnosis of mitochondrial mutations.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Assessment of CoQ10 dietary intake in a mediterranean cohort of familial hypercholesterolemia patients: a pilot study

  • Sanclemente, Teresa
  • Carazo, Alicia
  • Silvestre-Muñoz, Tania
  • Montoya, Julio
  • Ruiz-Pesini, Eduardo
  • Puzo, José
  • Pacheu-Grau, David
Background/Objectives: Coenzyme Q 10 is a lipid molecule that works as a mobile electron transporter in the mitochondrial respiratory chain and, in addition, plays the role of an antioxidant. Interestingly, CoQ10 synthesis in human cells derives from the mevalonate pathway, the same metabolic route that delivers endogenous cholesterol. Mutations leading to Familial Hypercholesterolemia (FH) alter the levels of CoQ10 production and remarkably, statin therapy associated muscular symptoms (SAMSs) might also be modulated by CoQ10 supplementation. CoQ10 is also provided by diet and only a few studies have calculated the dietary intake of this metabolite among populations. Methods: Here, we present our Spanish FH cohort (n = 261) and characterized relevant clinical, metabolic, and anthropometric parameters. Results: A cohort of 75.1% followed lipid-lowering treatment at inclusion, being the most prescribed drugs statin alone (32.7%) and statins combined with ezetimibe (56.6%). The average time on statin treatment was 3.7 years. Interestingly, 22% of cohort patients presented with SAMS. In addition, we performed an exhaustive literature review to define for the first time the CoQ10 content present in food typically found in Spain or other southern-European countries and classified them from very rich (over 50 mg/kg) to very poor (<1 mg/kg). With this information, we calculated the daily intake of CoQ10 from a small group (12) of selected FH patients using a validated food-frequency questionnaire (FFQ) and determined a daily intake 9.72 ± 2.64 mg/day, different to other described populations. Conclusions: we discussed the relevance of exogenous CoQ10 for FH development and potential SAMS. Interestingly, this information can be extrapolated to define the regular CoQ10 intake of the Spanish population, especially when following the MedDiet.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

ISR pathway contribution to tissue specificity of mitochondrial diseases

  • Vela-Sebastián, Ana
  • Bayona-Bafaluy, Pilar
  • Pacheu-Grau, David
Mitochondrial genetic defects caused by whole-body mutations typically affect different tissues in different ways. Elucidating the molecular determinants that cause certain cell types to be primarily affected has become a critical research target within the field. We propose a differential activation of the integrated stress response as a potential contributor to this tissue specificity.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Effects of Tributyltin Chloride on Human Neuronal Differentiation and Mice Brain Development

  • López-Gallardo, Ester
  • Meade, Patricia
  • Jiménez-Salvador, Irene
  • Hernández-Ainsa, Carmen
  • Iglesias, Eldris
  • Pesini, Alba
  • Garrido-Pérez, Nuria
  • Emperador, Sonia
  • Pacheu-Grau, David
  • Bayona-Bafaluy, Pilar
  • Ruiz-Pesini, Eduardo
According to the developmental origins of health and disease hypothesis, perinatal exposure to an environmental toxicant during the development of the nervous system could cause a permanent cellular modification that may promote the appearance of neurodegenerative diseases at an older age. Tributyltin chloride is an environmental pollutant that, among other effects, provokes a dysfunction of the oxidative phosphorylation system and has adverse effects on the nervous system. We studied neuronal differentiation of human neuroblastoma cells and neural stem cells in the presence of tributyltin chloride concentrations found in human blood (≤ 100 nM), and brain development in two-year-old mice after perinatal exposure to tributyltin chloride (≤ 1000 nM). Pregnant mice (8–9 weeks old) were exposed to TBTC (0, 100, 500, or 1000 nM) via drinking water throughout gestation and lactation and ended upon weaning of the pups. Genetic-molecular, biochemical and cellular studies were performed on human SH-SY5Y neuroblastoma cells and on neural stem cells differentiating into neurons. In addition to these studies, histological studies of the brain and functional tests were performed in two-year-old mice. A decrease in the oxidative phosphorylation activity, essential for the proper function of the nervous system, affected neuronal differentiation of human neural stem cells and neuroblastoma cells in vitro. Exposure to this compound during pregnancy and lactation resulted in a modification of global deoxyribonucleic acid methylation levels in 2-year-old mice. Additionally, various histological changes were detected in the brains of these mice. Therefore, the alteration of brain development with long-term consequences may be one of the manifestations of early exposure to tributyltin.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Reversible phosphorylation influences energetic cellular metabolism by modulating mitochondrial gene expression

  • Mainé-Rodrigo, Aldara
  • Vela-Sebastián, Ana
  • Pacheu-Grau, David
Mitochondria act as key metabolic regulators beyond ATP production, and the understanding of how cellular signaling modifies mitochondrial gene expression is currently being explored. Recent evidence links kinases such as mitogen-activated protein kinase-interacting kinases, hexokinase 1, and eukaryotic elongation factor 2 kinase to mitochondrial function, influencing metabolic adaptation, inflammation, and survival under nutrient stress, with implications for obesity and aging.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Infectious stress triggers a POLG-related mitochondrial disease

  • Gaudo, Paula
  • Emperador, Sonia
  • Garrido-Perez, Nuria
  • Ruiz-Pesini, Eduardo
  • Yubero, Delia
  • Garcia-Cazorla, Angels
  • Artuch, Rafael
  • Montoya, Julio
  • Bayona-Bafaluy, María Pilar
A 3-year-old girl presented with severe epilepsy in the context of Borrelia infection. After ceftriaxone/lidocaine administration, she showed secondarily generalized focal crises that led to neurological and motor sequelae. Genetic studies identified in the patient two heterozygous POLG mutations (c.2591A>G; p.Asn864Ser and c.3649G>C; p.Ala1217Pro). Through analysis of POLG activity in cultured fibroblasts, we confirmed that the mutations altered the mtDNA turnover. Moreover, patient fibroblasts were more sensitive than controls in the presence of a mitochondrial replication-affecting drug, the antiretroviral azidothymidine. To test if ceftriaxone treatment could worsen the deleterious effect of the patient mutations, toxicity assays were performed. Cell toxicity, without direct effect on mitochondrial respiratory function, was detected at different antibiotic concentrations. The clinical outcome, together with the different in vitro sensitivity to ceftriaxone among patient and control cells, suggested that the mitochondrial disease symptoms were hastened by the infection and were possibly worsened by the pharmacological treatment. This study underscores the benefit of early genetic diagnosis of the patients with mitochondrial diseases, since they may be a target group of patients especially vulnerable to environmental factors.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Otros (Other)

Hipersensibilidad mitocondrial al sevoflurano: la farmacogenética y el papel de las sociedades científicas

  • Hernández-Castillo, Y.
  • Ruiz-Pesini, E.
La práctica clínica es, en sí misma, medicina personalizada. La anamnesis ya representa una forma de individualización. El avance científico ha permitido que ahora la farmacogenética contribuya a esta individualización. La variabilidad en la respuesta a los anestésicos es un hecho bien establecido, y los factores genéticos parecen contribuir a estas diferencias interindividuales. Así, un mejor entendimiento de la interacción gen-anestésico puede ayudar a los anestesiólogos a identificar a los pacientes con sensibilidad atípica a estos compuestos. Sin embargo, las variantes genéticas solas raramente dan una explicación exhaustiva a la variabilidad observada en los pacientes, y muchas de las relaciones genotipo / fenotipo son multifactoriales, con otros factores genéticos y no genéticos jugando también papeles muy importantes en el desarrollo del fenotipo. Por ello, los clínicos deben ser conscientes de estas posibilidades...